Donepezil HCl & Cognitive Deficits in Autism

PHASE2CompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

October 31, 2002

Primary Completion Date

August 31, 2006

Study Completion Date

August 31, 2006

Conditions
Autistic Disorder
Interventions
DRUG

Donepezil HCl

Participants will start with 5 mg per day dose of donepezil HCl, then have their dose increased to 10mg per day after 4 weeks.

DRUG

Placebo

Placebo used in placed of Donepezil HCL

Trial Locations (1)

15213

Western Psychiatric Institute & Clinic, Pittsburgh

All Listed Sponsors
collaborator

National Institute of Mental Health (NIMH)

NIH

lead

University of Pittsburgh

OTHER

NCT00047697 - Donepezil HCl & Cognitive Deficits in Autism | Biotech Hunter | Biotech Hunter